Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-50
SponsorTanta University
About this trial
The aim of this study is to compare the safety and efficacy of theophylline, sumatriptan, and gabapentin in the treatment of post-dural puncture headache.
Eligibility criteria
Qualifiers
Age from 21 to 50 years.
Both sexes.
American Society of Anesthesiologists (ASA) physical status ≤ II.
Patient's selection for this study will be based on clinical diagnosis suggesting post-dural puncture headache (PDPH) based on the International Headache Society criteria.
Disqualifiers
Pregnant women.
History of; chronic headache, cluster headache, migraine, convulsions, cerebrovascular accident, and previous neurological diseases.
Signs of meningismus.
Dysrhythmia.
Trial design
Treatments tested in this trial
- Theophylline
- Sumatriptan
- Gabapentin
Treatment groups
75 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov